Cardiomyopathy of Friedreich's Disease. Modern Methods of Diagnostic
Open Access
- 3 March 2021
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (1), 105-110
- https://doi.org/10.20996/1819-6446-2021-01-05
Abstract
Friedreich's disease is a hereditary neurodegenerative multiple organ disease, primarily affecting the most energy-dependent tissues (cells of the nervous system, myocardium, pancreas), the lesion of which is characterized by progressive ataxia, dysarthria, dysphagia, oculomotor disorders, loss of deep tendon reflexes, pyramid signs, diabetes mellitus, visual impairment. Friedreich's ataxia is the most common of all hereditary ataxias; nevertheless, this disease is considered orphan. By its pathogenesis, Friedreich's disease is mitochondrial ataxia, caused by a deficiency in the transcription of the FXN gene, leading to a decrease in the synthesis of the frataxin protein. Frataxin is a protein associated with the inner mitochondrial membrane, which in turn is involved in the formation of iron-sulfur clusters, the lack of which leads to a decrease in the production of mitochondrial ATP, an increase in the level of mitochondrial iron and oxidative stress. The basis of the clinical picture of Friedreich's disease is ataxia of a mixed (sensitive and cerebellar) nature. The steady and gradual progression of neurological symptoms significantly affects the quality of life of patients and is most often the leading reason for seeking medical attention. However, the prognosis is primarily due to the involvement of cardiac tissue in the pathological process. The main causes of death in patients with Friedreich's ataxia are severe heart failure and sudden cardiac death due to cardiomyopathy. The overwhelming majority of foreign and domestic publications on Friedreich's ataxia are devoted to the neurological manifestations of this disease, and little attention is paid to this problem in the cardiological scientific and practical society. The purpose of this review is to provide up-to-date information on modern methods of diagnosing myocardial damage at various stages of Friedreich's disease.Keywords
This publication has 45 references indexed in Scilit:
- The Heart in Friedreich AtaxiaJournal of the American College of Cardiology, 2012
- Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich's ataxiaEuropean Heart Journal – Cardiovascular Imaging, 2011
- Early Changes in Left Ventricular Long-Axis Function in Friedreich Ataxia: Relation with the FXN Gene Mutation and Cardiac Structural ChangeJournal of the American Society of Echocardiography, 2011
- Friedreich's ataxia: Pathology, pathogenesis, and molecular geneticsJournal of the Neurological Sciences, 2011
- Cardiomyopathy of Friedreich’s Ataxia: Use of Mouse Models to Understand Human Disease and Guide Therapeutic DevelopmentPediatric Cardiology, 2011
- Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndromeEuropean Heart Journal, 2010
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJournal of Invasive Cardiology, 2009
- Myocardial ischemia in the absence of epicardial coronary artery disease in Friedreich's ataxiaJournal of Cardiovascular Magnetic Resonance, 2008
- Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxiaThe Cerebellum, 2006
- The varying evolution of friedreich's ataxia cardiomyopathyThe American Journal of Cardiology, 1996